Isk Ratio (M-H, Random, 95 CI) Risk Ratio (M-H, Random, 95 CI) Threat

Author manuscript; readily available in PMC 2014 June 12.Pe -Rosas et al.PageOutcome or subgroup title gestation or prior to pregnancy) 19.2 Late gestational age (supplementation began at 20 weeks of gestation or later) 19.three Unspecified gestational orage or mixed gestational ages in the get started of supplementation 20 Ndicator of iron status at 37 weeks' gestation or much more) (ALL) eight Maternal Maternal anaemia at term (Hb much less than 110 g/L at 37 weeks' gestation or a lot more) SUBGROUP Evaluation by anaemia status 20.1 Non-anaemic (Hb 110 g/L or above through very first and third trimesters or Hb 105 g/L or above if in second trimester) at start out of supplementation 20.2 Unspecified/ mixed anaemia status at begin of supplementation 21 Maternal anaemia at term (Hb less than 110 g/L at 37 weeks' gestation or far more) SUBGROUP Evaluation by weekly dose of iron 21.1 Low weekly dose of iron within the weekly group (120 mg E following the starvation of a fly with couple of alternatives. In elemental iron or much less per week) 21.two High weekly dose of iron within the weekly group (greater than 120 mg elemental iron per week) 22 Maternal anaemia at term (Hb significantly less than 110 g/L at 37 weeks' gestation or a lot more) SUBGROUP Analysis by intermittent regimen 22.1 Provision of iron when per week 22.two Other intermittent regimens 23 Maternal iron deficiency at term (based on any indicator of iron status at 37 weeks' gestation or extra) (ALL) 24 Maternal iron deficiency anaemia at term (Hb much less than 110 g/L and at least one added laboratoryNo. of studiesNo. of participantsStatistical methodEffect sizeRisk Ratio (M-H, Random, 95 CI)Europe PMC Funders Author Manuscripts Europe PMC Funders Author Manuscripts0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)1.20 [0.78, 1.83]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)three.77 [0.20, 71.87]Risk Ratio (M-H, Random, 95 CI)1.20 [0.78, 1.83]Risk Ratio (M-H, Random, 95 CI)1.22 [0.84, 1.80]Risk Ratio (M-H, Random, 95 CI)0.90 [0.52, 1.56]Risk Ratio (M-H, Random, 95 CI)1.51 [0.96, 2.37]Risk Ratio (M-H, Random, 95 CI)1.25 [0.78, 1.99]4607Risk Ratio (M-H, Random, 95 CI) Danger Ratio (M-H, Random, 95 CI)1.25 [0.78, 1.99] 0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)0.0 [0.0, 0.0]Risk Ratio (M-H, Random, 95 CI)0.71 [0.08, 6.63]Cochrane Database Syst Rev. Author manuscript; out there in PMC 2014 June 12.Pe -Rosas et al.PageOutcome or subgroup title indicators at 37 weeks gestation or a lot more) (ALL) 25 Maternal death (death though pregnant or within 42 days of termination of pregnancy) (ALL) 26 Unwanted side effects (any reported throughout intervention period) (ALL) title= cddis.2015.241 27 title= INF.0000000000000821 Unwanted side effects (any reported throughout intervention period) SUBGROUP Analysis by gestational age 27.1 Early gestational age (supplementation began prior to 20 weeks' gestation or prior to pregnancy) 27.2 Late gestational age (supplementation began at 20 weeks of gestation or later) 27.three Unspecified gestational age or mixed gestational ages in the commence of supplementation 28 Unwanted effects (any reported all through intervention period) SUBGROUP Evaluation by anaemia statusNo.